200+ liver transplants completed and robotic kidney transplant available for adults and children in Bangalore.
No. Indian law requires international patients to bring their own living donor who is a close first-degree relative.
Deceased donor organs from India's national registry are not available to foreign nationals.
This applies to kidney, liver, and all other organ transplants. Your donor travels to India with you and undergoes a full compatibility evaluation before the transplant committee approves the procedure.
Yes. Aster CMI is NABH and NABL accredited and the first hospital in South India to hold NABH Platinum Digital Health Certification. The Multi-Organ Transplant Centre of Excellence follows protocols aligned with international transplant guidelines.
The team uses OrganOx Metra for donor liver preservation, a technology available at only a handful of centres across Asia. The hospital was ranked #12 Best Hospital in India by Newsweek in 2026 and #1 in Bangalore by the Times Health Survey in 2023.
Organ transplant appointments and treatment planning at Aster CMI Hospital in Bangalore are coordinated through the My 1Health International Patient Care team, available 24/7.
The team arranges specialist consultations, reviews your reports before travel, confirms donor eligibility, provides a written cost estimate, and coordinates visa support, airport transfers, and post-transplant follow-up.
You and your donor should arrive 2-3 weeks before surgery for evaluation and transplant committee approval. Typical lengths of stay after surgery:
Post-discharge follow-up is managed remotely through online consultations and digital access to your medical records.
Transplant costs at Aster CMI vary depending on the type of transplant, case complexity, length of stay, and post-operative care required. A written, itemised cost estimate is provided before you travel. Contact the international patient team via WhatsApp or email with your medical reports to receive a personalised figure.
Aster CMI Hospital's liver transplant programme has a 92%+ success rate across 200+ procedures, with donor morbidity held at 3% and zero donor deaths recorded to date.
Kidney transplant outcomes are comparable to international benchmarks of 94-98%. Individual results depend on the patient's condition, donor compatibility, and post-operative adherence to immunosuppressant therapy.